Design, Synthesis, and Pharmacological Screening of Pyridazinone Hybrids as Anticonvulsant Agents
- 1 September 2017
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 350 (10)
Abstract
A series of new hybrid benzimidazole containing pyridazinones derivatives were designed and synthesized in accordance with the pharmacophoric requirements essential for the anticonvulsant activity. The synthesized compounds were evaluated for anticonvulsant activity on mice by the gold standard maximal electroshock (MES) and subcutaneous pentylenetetrazole (scPTZ)‐induced seizure models. Among the compounds tested,SS‐4Fshowed significant anticonvulsant activity in both the screens with ED50values of 25.10 and 85.33 mg/kg in the MES and scPTZ screens, respectively. CompoundSS‐4Femerged as safer and effective anticonvulsant due to its several‐fold higher protective indices. Further, the gamma‐aminobutyric acid (GABA) estimation result showed a marked increase in the GABA level (1.7‐fold) as compared to the control, which was further confirmed by good binding properties with the GABAAreceptor.Keywords
Funding Information
- University Grants Commission (49053)
This publication has 39 references indexed in Scilit:
- Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotectiveEuropean Journal of Medicinal Chemistry, 2012
- Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligandsNature Chemical Biology, 2012
- Triazole incorporated pyridazinones as a new class of antihypertensive agents: Design, synthesis and in vivo screeningBioorganic & Medicinal Chemistry Letters, 2011
- Molecular Model of Anticonvulsant Drug Binding to the Voltage-Gated Sodium Channel Inner PoreMolecular Pharmacology, 2010
- Synthesis, characterization and antihypertensive activity of pyridazinone derivativesEuropean Journal of Medicinal Chemistry, 2010
- Synthesis and calculated log P correlation of imidooxy anticonvulsantsJournal of Medicinal Chemistry, 1993
- Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activityJournal of Medicinal Chemistry, 1987
- Selective thromboxane synthetase inhibitors and antihypertensive agents. New derivatives of 4-hydrazino-5H-pyridazino[4,5-b]indole, 4-hydrazinotriazino[4,5-a]indole, and related compoundsJournal of Medicinal Chemistry, 1987
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983
- A Note on a Simple Apparatus for Detecting Neurological Deficit in Rats and Mice**College of Pharmacy, University of Nebraska, Lincoln 8.Journal of the American Pharmaceutical Association (Scientific ed.), 1957